4th mRNA-Based Therapeutics Summit

Conference themes
2023 saw the Nobel Prize awarded to mRNA technology, reinvigorating the field and spurring a new wave of candidates entering the clinic. The industry has made tremendous strides in applying mRNA technology beyond COVID-19, and as mRNA unlocks the rare, infectious and oncological spaces, the 4th mRNA-Based Therapeutics Summit maintains its position as the world's most comprehensive, end-to-end industry-dedicated conference, bringing you exclusive scientific and strategic insights

Professional congress organizer (PCO)
Hanson Wade

Notes
Brochure: https://go.evvnt.com/2261640-3?pid=4832

Speakers: Ajan Reginald, Chief Executive Officer, Roquefort Therapeutics, Alexander Zehnder, Chief Executive Officer, CureVacSE, Andrew Allen, Chief Executive Officer, Gritstone bio, Inc., and more

https://go.evvnt.com/2261640-2?pid=4832

Ms. Rosie Andre